| __timestamp | Vertex Pharmaceuticals Incorporated | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 855506000 | 293000 |
| Thursday, January 1, 2015 | 996170000 | 1002000 |
| Friday, January 1, 2016 | 1047690000 | 888000 |
| Sunday, January 1, 2017 | 1324625000 | 19623000 |
| Monday, January 1, 2018 | 1416476000 | 30421000 |
| Tuesday, January 1, 2019 | 1754540000 | 34794000 |
| Wednesday, January 1, 2020 | 1829537000 | 28304000 |
| Friday, January 1, 2021 | 3051100000 | 56886000 |
| Saturday, January 1, 2022 | 2540300000 | 100894000 |
| Sunday, January 1, 2023 | 3162900000 | 159765000 |
| Monday, January 1, 2024 | 3630300000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Vertex Pharmaceuticals Incorporated has consistently demonstrated its leadership in this arena. From 2014 to 2023, Vertex's R&D expenses have surged by nearly 270%, peaking at over $3.16 billion in 2023. This substantial investment underscores Vertex's dedication to pioneering treatments and maintaining its competitive edge.
In contrast, Viridian Therapeutics, Inc., while smaller in scale, has shown a remarkable growth trajectory in its R&D spending. Starting from a modest $293,000 in 2014, Viridian's expenses have increased exponentially, reaching approximately $160 million in 2023. This growth reflects Viridian's strategic focus on expanding its research capabilities and developing innovative therapies.
The data highlights the dynamic nature of the biotech industry, where strategic R&D investments are pivotal for long-term success.
Comparing Innovation Spending: Sanofi and Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated vs BeiGene, Ltd.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Ascendis Pharma A/S
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs ImmunityBio, Inc.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Xencor, Inc. Allocate Funds
Research and Development Investment: Biogen Inc. vs Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Viridian Therapeutics, Inc.
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for HUTCHMED (China) Limited and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Iovance Biotherapeutics, Inc. and Viridian Therapeutics, Inc.